Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-26 @ 10:45 PM
Ignite Modification Date: 2025-12-26 @ 10:45 PM
NCT ID: NCT00816712
Eligibility Criteria: Inclusion Criteria: * Subject is weight stable over the past 3 months * Patient agrees to refrain from consumption of alcohol from 48 hours prior to entering the study * Subject agrees to follow the study restriction of no caffeine while on study * Patient agrees to following the meat-free controlled protein weight-maintaining diet * Patient is willing to avoid strenuous physical activity * Patient has been a nonsmoker for at least 6 months prior to study start Exclusion Criteria: * Subject is currently a regular user of any illicit drugs * Subject has taken androgenic steroids in the previous 12 months * Subject has participated in sports events, resistance exercise training or heavy exercise in the previous month * Subject has prostate cancer * Subject has a history of cancer except basal-cell tumors * Subject has been diagnosed with HIV * Subject has been diagnosed with Hepatitis B or C * Subject uses certain anti-inflammatory drugs such as ibuprofen, arcoxia or celecoxib * Subject uses a blood anticoagulant, such as Coumadin (Warfarin) or high doses of aspirin * Subject is currently taking over the counter supplements such as "muscle builders" or "fat burners" * Subject has an allergy or hypersensitivity to intramuscular testosterone * Subject has sciatica * Subject has donated blood products or has had phlebotomy within 2 months of signing informed consent * Subject has undergone a surgical procedure within 1 month of signing informed consent * Subject is currently participating or has participated in a study with an investigational drug or device
Healthy Volunteers: True
Sex: MALE
Minimum Age: 60 Years
Maximum Age: 70 Years
Study: NCT00816712
Study Brief:
Protocol Section: NCT00816712